View More Recent Stories
-
Human Genome (HGSI) July put volatility elevated at 65, October at 75
-
Stocks with implied volatility below index mean range; HGSI AIG C
-
Human Genome (HGSI) June volatility at 66, October at 73
-
Human Genome (HGSI) options active; shares down 10% on efficacy data
-
Human Genome volatility flat; shares near nine-year high into EPS
-
Human Genome (HGSI) volatility flat at 58
-
Human Genome (HGSI) February volatility at 47, April at 53
